|
1D4M
THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION
Deposited 1999-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-MERIC
|
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded
|
W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 120
MYR MYRISTIC ACID × 60
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1D4M
THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION
Deposited 1999-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded
|
W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 2
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1D4M
THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION
Deposited 1999-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 20
PDB declaration: eicosameric
|
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded
|
W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 10
MYR MYRISTIC ACID × 5
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1D4M
THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION
Deposited 1999-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 24
PDB declaration: 24-meric
|
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded
|
W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 12
MYR MYRISTIC ACID × 6
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1D4M
THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION
Deposited 1999-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded
|
W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 2
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
1D4M
THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION
Deposited 1999-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 120
PDB declaration: 120-meric
|
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded
|
W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 60
MYR MYRISTIC ACID × 30
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
8AT5
native Coxsackievirus A9
Deposited 2022-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
MYR MYRISTIC ACID × 60
PLM PALMITIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.25;PBS containing 2mM MgCl2, pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
8AW6
Expanded Coxsackievirus A9 after 0.01% faf-BSA treatment
Deposited 2022-08-29
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-meric
|
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.25;DPBS containing 0.01% faf-BSA, pH 7.25, incubated at 37 C for 1 h
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
8AXX
Expanded Coxsackievirus A9 after treatment with endosomal ionic buffer
Deposited 2022-09-01
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 180
PDB declaration: 180-meric
|
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.25;endosomal ionic composition buffer, pH 7.25, incubated at 37 C for 3 h
20 mM NaCl, 6 mM KH2PO4, 12 mM K2HPO4, 0.5 mM MgCl2, 0.45 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
8S7J
Coxsackievirus A9 bound with compound 20 (CL300)
Deposited 2024-03-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
A1H9Q ~{N}-[(4-methoxyphenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.26 Å
|
|
9EXI
Coxsackievirus A9 bound with compound 14 (CL275)
Deposited 2024-04-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–851(283 aa)
Chain B
79–329(251 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
A1H8J 4-[(4-methylpiperazin-1-yl)methyl]-N-[[4-(trifluoromethyl)phenyl]methyl]aniline × 60
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.31 Å
|
|
9FA9
Coxsackievirus A9 bound with compound 16 (CL298)
Deposited 2024-05-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–851(283 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
A1IBS ~{N}-[(2-fluorophenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.75 Å
|
|
9FCZ
Coxsackievirus A9 bound with compound 17 (CL301)
Deposited 2024-05-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–851(283 aa)
Chain B
79–329(251 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
A1IB2 ~{N}-[(3-fluorophenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.53 Å
|
|
9FGN
Coxsackievirus A9 bound with compound 18 (CL304)
Deposited 2024-05-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–850(282 aa)
Chain B
79–328(250 aa)
Chain C
332–567(236 aa)
Chain D
2–68(67 aa)
|
Not recorded
|
A1ICH ~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.64 Å
|
|
9FO2
Coxsackievirus A9 bound with compound 15 (CL278)
Deposited 2024-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–867(299 aa)
Chain B
79–329(251 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
A1IEI ~{N}-[(4-fluorophenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was blotted from the front for 1.5 s.
|
Resolution 2.58 Å
|
|
9FO5
Coxsackievirus A9 bound with compound 19 (CL313)
Deposited 2024-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
A1IEH ~{N}-[[3,4-bis(fluoranyl)phenyl]methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.69 Å
|
|
9FP5
Coxsackievirus A9 bound with CL213.
Deposited 2024-06-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 240
PDB declaration: 240-meric
|
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded
|
PLM PALMITIC ACID × 60
MYR MYRISTIC ACID × 60
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.50 Å
|